当前位置: X-MOL 学术Lancet › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Extended-release naltrexone: good but not a panacea
The Lancet ( IF 98.4 ) Pub Date : 2017-11-14 , DOI: 10.1016/s0140-6736(17)32872-6
David C Lott

Unlike other addictions, opioid-use disorder has several highly effective medication treatments available, in particular methadone, buprenorphine, and naltrexone.1–3 Methadone is the least accessible or acceptable of these in many settings, so providers and patients are often faced with a choice between buprenorphine-naloxone (BUP-NX) and extended-release naltrexone injection (XR-NTX).

中文翻译:

缓释纳曲酮:良,但不是万能药

与其他成瘾不同,阿片类药物使用障碍有几种有效的药物治疗方法,特别是美沙酮,丁丙诺啡和纳曲酮。在许多情况下,1-3美沙酮是最难获得或接受的药物,因此提供者和患者通常会在丁丙诺啡-纳洛酮(BUP-NX)和缓释纳曲酮注射液(XR-NTX)之间进行选择。
更新日期:2018-01-26
down
wechat
bug